FR2824327B1 - Particules pseudovirales de birnavirus - Google Patents

Particules pseudovirales de birnavirus

Info

Publication number
FR2824327B1
FR2824327B1 FR0105858A FR0105858A FR2824327B1 FR 2824327 B1 FR2824327 B1 FR 2824327B1 FR 0105858 A FR0105858 A FR 0105858A FR 0105858 A FR0105858 A FR 0105858A FR 2824327 B1 FR2824327 B1 FR 2824327B1
Authority
FR
France
Prior art keywords
birnavirus
pseudoviral particles
pseudoviral
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0105858A
Other languages
English (en)
Other versions
FR2824327A1 (fr
Inventor
Bernard Delmas
Christophe Chevalier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Priority to FR0105858A priority Critical patent/FR2824327B1/fr
Priority to PCT/FR2002/001482 priority patent/WO2002088339A2/fr
Priority to AU2002310654A priority patent/AU2002310654A1/en
Publication of FR2824327A1 publication Critical patent/FR2824327A1/fr
Application granted granted Critical
Publication of FR2824327B1 publication Critical patent/FR2824327B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2720/10045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
FR0105858A 2001-05-02 2001-05-02 Particules pseudovirales de birnavirus Expired - Fee Related FR2824327B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0105858A FR2824327B1 (fr) 2001-05-02 2001-05-02 Particules pseudovirales de birnavirus
PCT/FR2002/001482 WO2002088339A2 (fr) 2001-05-02 2002-04-29 Particules pseudovirales de birnavirus
AU2002310654A AU2002310654A1 (en) 2001-05-02 2002-04-29 Bursal disease virus-like particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105858A FR2824327B1 (fr) 2001-05-02 2001-05-02 Particules pseudovirales de birnavirus

Publications (2)

Publication Number Publication Date
FR2824327A1 FR2824327A1 (fr) 2002-11-08
FR2824327B1 true FR2824327B1 (fr) 2003-07-11

Family

ID=8862894

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0105858A Expired - Fee Related FR2824327B1 (fr) 2001-05-02 2001-05-02 Particules pseudovirales de birnavirus

Country Status (3)

Country Link
AU (1) AU2002310654A1 (fr)
FR (1) FR2824327B1 (fr)
WO (1) WO2002088339A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2217967B1 (es) * 2003-03-31 2006-01-01 Consejo Sup. Investig. Cientificas Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
ES2307346B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2307345B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
EP2093281A1 (fr) * 2008-02-19 2009-08-26 Kapsid Link, S.L. Nanoporteurs de protéines, procédé pour les obtenir et applications
ES2659586T3 (es) * 2008-05-09 2018-03-16 Chimera Pharma S.L.U. Proteínas de fusión quiméricas y partículas similares a virus de VP2 de Birnavirus
WO2011054995A2 (fr) * 2009-11-06 2011-05-12 Chimera Pharma, S. L. U. Vaccins prophylactiques contre la grippe obtenus à partir de capsides virales de birnavirus contenant l'antigène m2e du virus de la grippe
CN102145166B (zh) * 2011-04-21 2013-05-22 江苏省农业科学院 重组禽流感M2e的鸡传染性法氏囊VP2亚单位疫苗、其构建方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10399004I2 (de) * 1985-05-30 2005-09-08 Commw Scient Ind Res Org Klonierung und expression von Wirtssch}tzenden immunogenen des Infektioesen Bursavirus (ibdv).
JPH02500409A (ja) * 1987-07-27 1990-02-15 シントロ・コーポレイシヨン 弱毒化ヘルペスウイルス、アミノ酸配列コード化外来ｄｎａ含有ヘルペスウイルス並びに同上含有ワクチン
CA2110505A1 (fr) * 1991-07-26 1993-02-18 Enzo Paoletti Vaccin poxvirus recombinant contre le virus de la bursite infectieuse
US6231868B1 (en) * 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts

Also Published As

Publication number Publication date
FR2824327A1 (fr) 2002-11-08
AU2002310654A1 (en) 2002-11-11
WO2002088339A3 (fr) 2004-01-22
WO2002088339A2 (fr) 2002-11-07

Similar Documents

Publication Publication Date Title
DE60215618D1 (de) Zerstäuber
NO20033384D0 (no) Farmasöytisk formulering
DE60207663D1 (de) Bürstendichtung und Bürstendichtungsanordnung
ATE296619T1 (de) Feste orale dosierungsform von simethicon
DK1414409T3 (da) Stabiliseret oral suspensionsformulering
FI20011478A (fi) Farmaseuttinen koostumus
FR2837930B1 (fr) Detecteur bidimensionnel de particules ionisantes
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20033785D0 (no) Farmasöytisk formulering
FR2827163B1 (fr) Mascara comprenant une dispersion de particules
BR0201972B1 (pt) montante de suspensão.
FR2827160B1 (fr) Composition cosmetique comprenant une dispersion de particules
EE05020B1 (et) Glburiidi ravimkoostis
DE50208287D1 (de) Bicyclische n-arylamide
DE60122577D1 (de) Zweikomponenten zahnpasta zur unterdrückung von mundgeruch
IS7051A (is) Lyfjasamsetningar
FI20010558A0 (fi) Kappaleiden paikannus
DE60208700D1 (de) Schälgerät und zugehörige verfahren
FR2827166B1 (fr) Mascara comprenant des particules solides
FR2827167B1 (fr) Mascara comprenant des particules solides
ITTO20020789A1 (it) Formulazione solida
NO20041968L (no) Anvendelse av cystationin
FR2824327B1 (fr) Particules pseudovirales de birnavirus
FR2819176B1 (fr) Composition cosmetique pelable
FR2833982B1 (fr) Plaque de platre

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060131